verified SJR 0,944 · Q2 • database Scopus / SJR & Web of Science & DOAJ indexed

New Zealand · Dove Medical Press Ltd

workspace_premium Q2 — Oncology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Breast Cancer: Targets and Therapy

Breast Cancer: Targets and Therapy is a journal indexed in SJR in Oncology with an H index of 46. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1762,2 €. The scope of the journal is focused on breast cancer, anticancer agents, screening, therapy, palliative care. It has an SJR impact factor of 0,944 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,944.

Publisher: Dove Medical Press Ltd

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,944 Q2

H-index 46

Acceptance rate pie_chart

35%

Source Acceptance_Rate

Time to publication hourglass_top

16 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.762 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,944

H-index

46

Docs (year)

76

Docs 3y

177

Total refs

3309

Cites 3y

615

Citable 3y

171

Cites/Doc 2y

3.25

Ref/Doc

43.54

Immediate OA

1762,2 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review